BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Troxell ML, Brunner AL, Neff T, Warrick A, Beadling C, Montgomery K, Zhu S, Corless CL, West RB. Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions. Mod Pathol. 2012;. [PMID: 22460814 DOI: 10.1038/modpathol.2012.55] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Flatley E, Ang D, Warrick A, Beadling C, Corless CL, Troxell ML. PIK3CA-AKT pathway mutations in micropapillary breast carcinoma. Hum Pathol 2013;44:1320-7. [PMID: 23352210 DOI: 10.1016/j.humpath.2012.10.018] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
2 Guillet C, Rechsteiner M, Bellini E, Choschzick M, Moskovszky L, Dedes K, Papassotiropoulos B, Varga Z. Juvenile papillomatosis of the breast (Swiss cheese disease) has frequent associations with PIK3CA and/or AKT1 mutations. Hum Pathol 2020;98:64-73. [PMID: 32088208 DOI: 10.1016/j.humpath.2020.02.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kehr EL, Jorns JM, Ang D, Warrick A, Neff T, Degnin M, Lewis R, Beadling C, Corless CL, Troxell ML. Mucinous breast carcinomas lack PIK3CA and AKT1 mutations. Human Pathology 2012;43:2207-12. [DOI: 10.1016/j.humpath.2012.03.012] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
4 Eberle CA, Piscuoglio S, Rakha EA, Ng CK, Geyer FC, Edelweiss M, Sakr RA, Weigelt B, Reis-Filho JS, Ellis IO. Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile. Histopathology 2016;68:1030-9. [PMID: 26497122 DOI: 10.1111/his.12897] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
5 Cui W, Cai Y, Zhou X. Advances in subunits of PI3K class I in cancer. Pathology. 2014;46:169-176. [PMID: 24614719 DOI: 10.1097/pat.0000000000000066] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
6 Bhargava R, Florea AV, Pelmus M, Jones MW, Bonaventura M, Wald A, Nikiforova M. Breast Tumor Resembling Tall Cell Variant of Papillary Thyroid Carcinoma: A Solid Papillary Neoplasm With Characteristic Immunohistochemical Profile and Few Recurrent Mutations. Am J Clin Pathol 2017;147:399-410. [PMID: 28375433 DOI: 10.1093/ajcp/aqx016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
7 Afghahi A, Forgó E, Mitani AA, Desai M, Varma S, Seto T, Rigdon J, Jensen KC, Troxell ML, Gomez SL, Das AK, Beck AH, Kurian AW, West RB. Chromosomal copy number alterations for associations of ductal carcinoma in situ with invasive breast cancer. Breast Cancer Res 2015;17:108. [PMID: 26265211 DOI: 10.1186/s13058-015-0623-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
8 Sato S, Maki S, Yamanaka T, Hoshino D, Ota Y, Yoshioka E, Kawachi K, Washimi K, Suzuki M, Ohkubo Y, Yokose T, Yamashita T, Ohtori S, Miyagi Y. Machine learning-based image analysis for accelerating the diagnosis of complicated preneoplastic and neoplastic ductal lesions in breast biopsy tissues. Breast Cancer Res Treat 2021;188:649-59. [PMID: 33934277 DOI: 10.1007/s10549-021-06243-2] [Reference Citation Analysis]
9 Liau JY, Lan J, Hong JB, Tsai JH, Kuo KT, Chu CY, Sheen YS, Huang WC. Frequent PIK3CA-activating mutations in hidradenoma papilliferums. Hum Pathol 2016;55:57-62. [PMID: 27184479 DOI: 10.1016/j.humpath.2016.04.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
10 Huang WS, Wang TB, He Y, Chen YJ, Zhong SL, Tan M. Phosphoinositide-3-kinase, catalytic, alpha polypeptide RNA interference inhibits growth of colon cancer cell SW948. World J Gastroenterol 2012; 18(26): 3458-3464 [PMID: 22807617 DOI: 10.3748/wjg.v18.i26.3458] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
11 Lin CY, Vennam S, Purington N, Lin E, Varma S, Han S, Desa M, Seto T, Wang NJ, Stehr H, Troxell ML, Kurian AW, West RB. Genomic landscape of ductal carcinoma in situ and association with progression. Breast Cancer Res Treat 2019;178:307-16. [PMID: 31420779 DOI: 10.1007/s10549-019-05401-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
12 Jahn SW, Kashofer K, Thüringer A, Abete L, Winter E, Eidenhammer S, Viertler C, Tavassoli F, Moinfar F. Mutation Profiling of Usual Ductal Hyperplasia of the Breast Reveals Activating Mutations Predominantly at Different Levels of the PI3K/AKT/mTOR Pathway. Am J Pathol 2016;186:15-23. [PMID: 26718977 DOI: 10.1016/j.ajpath.2015.09.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
13 Pang JM, Gorringe KL, Fox SB. Ductal carcinoma in situ - update on risk assessment and management. Histopathology 2016;68:96-109. [PMID: 26768032 DOI: 10.1111/his.12796] [Cited by in Crossref: 33] [Cited by in F6Publishing: 24] [Article Influence: 5.5] [Reference Citation Analysis]
14 Clay MR, Varma S, West RB. MAST2 and NOTCH1 translocations in breast carcinoma and associated pre-invasive lesions. Hum Pathol 2013;44:2837-44. [PMID: 24140425 DOI: 10.1016/j.humpath.2013.08.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ang D, Ballard M, Beadling C, Warrick A, Schilling A, O'Gara R, Pukay M, Neff TL, West RB, Corless CL, Troxell ML. Novel mutations in neuroendocrine carcinoma of the breast: possible therapeutic targets. Appl Immunohistochem Mol Morphol 2015;23:97-103. [PMID: 25679062 DOI: 10.1097/PDM.0b013e3182a40fd1] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 3.9] [Reference Citation Analysis]
16 Kutasovic JR, McCart Reed AE, Sokolova A, Lakhani SR, Simpson PT. Morphologic and Genomic Heterogeneity in the Evolution and Progression of Breast Cancer. Cancers (Basel) 2020;12:E848. [PMID: 32244556 DOI: 10.3390/cancers12040848] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
17 Newburger DE, Kashef-Haghighi D, Weng Z, Salari R, Sweeney RT, Brunner AL, Zhu SX, Guo X, Varma S, Troxell ML, West RB, Batzoglou S, Sidow A. Genome evolution during progression to breast cancer. Genome Res 2013;23:1097-108. [PMID: 23568837 DOI: 10.1101/gr.151670.112] [Cited by in Crossref: 83] [Cited by in F6Publishing: 70] [Article Influence: 9.2] [Reference Citation Analysis]
18 Weng Z, Spies N, Zhu SX, Newburger DE, Kashef-Haghighi D, Batzoglou S, Sidow A, West RB. Cell-lineage heterogeneity and driver mutation recurrence in pre-invasive breast neoplasia. Genome Med 2015;7:28. [PMID: 25918554 DOI: 10.1186/s13073-015-0146-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
19 Liau J, Lee Y, Tsai J, Yuan C, Chu C, Hong J, Sheen Y. Frequent PIK3CA activating mutations in nipple adenomas. Histopathology 2017;70:195-202. [DOI: 10.1111/his.13043] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
20 Sakr RA, Weigelt B, Chandarlapaty S, Andrade VP, Guerini-Rocco E, Giri D, Ng CK, Cowell CF, Rosen N, Reis-Filho JS, King TA. PI3K pathway activation in high-grade ductal carcinoma in situ--implications for progression to invasive breast carcinoma. Clin Cancer Res 2014;20:2326-37. [PMID: 24634376 DOI: 10.1158/1078-0432.CCR-13-2267] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 4.3] [Reference Citation Analysis]
21 Ang D, O'Gara R, Schilling A, Beadling C, Warrick A, Troxell ML, Corless CL. Novel method for PIK3CA mutation analysis: locked nucleic acid--PCR sequencing. J Mol Diagn 2013;15:312-8. [PMID: 23541593 DOI: 10.1016/j.jmoldx.2012.12.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
22 Ang D, VanSandt AM, Beadling C, Warrick A, West RB, Corless CL, Troxell ML. Biphasic papillary and lobular breast carcinoma with PIK3CA and IDH1 mutations. Diagn Mol Pathol 2012;21:221-4. [PMID: 23111200 DOI: 10.1097/PDM.0b013e31826ddbd1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
23 Rudolph M, Anzeneder T, Schulz A, Beckmann G, Byrne AT, Jeffers M, Pena C, Politz O, Köchert K, Vonk R, Reischl J. AKT1 (E17K) mutation profiling in breast cancer: prevalence, concurrent oncogenic alterations, and blood-based detection. BMC Cancer 2016;16:622. [PMID: 27515171 DOI: 10.1186/s12885-016-2626-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
24 Grünewald I, Vollbrecht C, Meinrath J, Meyer MF, Heukamp LC, Drebber U, Quaas A, Beutner D, Hüttenbrink KB, Wardelmann E, Hartmann W, Büttner R, Odenthal M, Stenner M. Targeted next generation sequencing of parotid gland cancer uncovers genetic heterogeneity. Oncotarget 2015;6:18224-37. [PMID: 26053092 DOI: 10.18632/oncotarget.4015] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 9.5] [Reference Citation Analysis]
25 Brunner AL, Li J, Guo X, Sweeney RT, Varma S, Zhu SX, Li R, Tibshirani R, West RB. A shared transcriptional program in early breast neoplasias despite genetic and clinical distinctions. Genome Biol 2014;15:R71. [PMID: 24887547 DOI: 10.1186/gb-2014-15-5-r71] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.8] [Reference Citation Analysis]
26 Pang JM, Gorringe KL, Wong SQ, Dobrovic A, Campbell IG, Fox SB. Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast. Breast Cancer Res 2015;17:80. [PMID: 26078038 DOI: 10.1186/s13058-015-0586-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
27 Al-sukhun S, Lataifeh I, Al-sukhun R. Defining the Prognostic and Predictive Role of PIK3CA Mutations: Sifting Through the Conflicting Data. Curr Breast Cancer Rep 2016;8:73-9. [DOI: 10.1007/s12609-016-0215-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
28 C Ang D, Warrick AL, Shilling A, Beadling C, Corless CL, Troxell ML. Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions. Mod Pathol 2014;27:740-50. [DOI: 10.1038/modpathol.2013.197] [Cited by in Crossref: 35] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]